These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10075625)

  • 1. Primaquine prophylaxis against malaria.
    Heppner DG; Gasser RA; Kester KE
    Ann Intern Med; 1999 Mar; 130(6):536; author reply 536-7. PubMed ID: 10075625
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of malaria].
    Botella de Maglia J; Espacio Casanovas A
    Rev Clin Esp; 1999 Aug; 199(8):549-50. PubMed ID: 10522443
    [No Abstract]   [Full Text] [Related]  

  • 3. [Association of methemoglobinemia and glucose-6-phosphate dehydrogenase deficiency in malaria patients treated with primaquine].
    Santana MS; da Rocha MA; Arcanjo AR; Sardinha JF; Alecrim WD; Alecrim Md
    Rev Soc Bras Med Trop; 2007; 40(5):533-6. PubMed ID: 17992408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity. A randomized, double-blind, placebo-controlled trial.
    Soto J; Toledo J; Rodriquez M; Sanchez J; Herrera R; Padilla J; Berman J
    Ann Intern Med; 1998 Aug; 129(3):241-4. PubMed ID: 9696733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primaquine for prevention of malaria in travelers.
    Baird JK; Fryauff DJ; Hoffman SL
    Clin Infect Dis; 2003 Dec; 37(12):1659-67. PubMed ID: 14689349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria.
    Fryauff DJ; Baird JK; Basri H; Sumawinata I; Purnomo ; Richie TL; Ohrt CK; Mouzin E; Church CJ; Richards AL
    Lancet; 1995 Nov; 346(8984):1190-3. PubMed ID: 7475658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethics, economics, and the use of primaquine to reduce falciparum malaria transmission in asymptomatic populations.
    Lubell Y; White L; Varadan S; Drake T; Yeung S; Cheah PY; Maude RJ; Dondorp A; Day NP; White NJ; Parker M
    PLoS Med; 2014 Aug; 11(8):e1001704. PubMed ID: 25137246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Widespread use of primaquine for control of Plasmodium vivax epidemics in a population with varying degrees of G6PD deficiency].
    Kondrashin AV; Baranova AM; Sergiev VP
    Med Parazitol (Mosk); 2010; (4):24-8. PubMed ID: 21400709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, randomized, placebo-controlled assessment of chloroquine/primaquine prophylaxis for malaria in nonimmune Colombian soldiers.
    Soto J; Toledo J; Rodriquez M; Sanchez J; Herrera R; Padilla J; Berman J
    Clin Infect Dis; 1999 Jul; 29(1):199-201. PubMed ID: 10433587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal Primaquine-Induced Hemolysis in a Patient With Plasmodium vivax Malaria and G6PD A(-) Variant in the Brazilian Amazon.
    Monteiro WM; Moura-Neto JP; Recht J; Bassat Q; Lacerda MV
    Clin Infect Dis; 2016 May; 62(9):1188. PubMed ID: 26826373
    [No Abstract]   [Full Text] [Related]  

  • 11. Tolerability and safety of primaquine in Papua New Guinean children 1 to 10 years of age.
    Betuela I; Bassat Q; Kiniboro B; Robinson LJ; Rosanas-Urgell A; Stanisic D; Siba PM; Alonso PL; Mueller I
    Antimicrob Agents Chemother; 2012 Apr; 56(4):2146-9. PubMed ID: 22252800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G6PD deficiency: global distribution, genetic variants and primaquine therapy.
    Howes RE; Battle KE; Satyagraha AW; Baird JK; Hay SI
    Adv Parasitol; 2013; 81():133-201. PubMed ID: 23384623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and laboratorial alterations in Plasmodium vivax malaria patients and glucose-6-phosphate dehydrogenase deficiency treated with primaquine at 0.50 mg/kg/day].
    Silva MC; Santos EB; Costal EG; Filho MG; Guerreiro JF; Póvoa MM
    Rev Soc Bras Med Trop; 2004; 37(3):215-7. PubMed ID: 15330059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malaria in a nonimmune population after extended chloroquine or primaquine prophylaxis.
    Fryauff DJ; Baird JK; Purnomo ; Awalludin M; Jones T; Subianto B; Richie TL; Tjitra E; Wignall FS; Hoffman SL
    Am J Trop Med Hyg; 1997 Feb; 56(2):137-40. PubMed ID: 9080870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primaquine: the risks and the benefits.
    Ashley EA; Recht J; White NJ
    Malar J; 2014 Nov; 13():418. PubMed ID: 25363455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of weekly primaquine in G6PD deficient patient with relapsing vivax malaria: A case report.
    Savargaonkar D; Ahmed MZ; Anvikar AR; Valecha N
    J Vector Borne Dis; 2017; 54(3):287-290. PubMed ID: 29097646
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemolysis and primaquine treatment. Preliminary report].
    Menéndez Capote R; Díaz Pérez L; Luzardo Suárez C
    Rev Cubana Med Trop; 1997; 49(2):136-8. PubMed ID: 9685977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primaquine prophylaxis against malaria.
    Barry M
    Ann Intern Med; 1999 Mar; 130(6):536-7. PubMed ID: 10075624
    [No Abstract]   [Full Text] [Related]  

  • 19. Malaria in pregnancy.
    Whitty CJ; Edmonds S; Mutabingwa TK
    BJOG; 2005 Sep; 112(9):1189-95. PubMed ID: 16101595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reinventing primaquine for endemic malaria.
    Baird JK
    Expert Opin Emerg Drugs; 2012 Dec; 17(4):439-44. PubMed ID: 22998791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.